| IRAK1 |
IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 |
CARD15 |
NOD2, CARD15, IBD1: Nucleotide-binding oligomerization domain-containing protein |
0.425 |
Evidence |
|
| IRAK1 |
IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 |
IFIH1 |
IFIH1, MDA5, RH116: Interferon-induced helicase C domain-containing protein 1 |
0.425 |
Evidence |
|
| ASCL1 |
ASCL1, ASH1: Achaete-scute homolog 1 |
ARNT2 |
ARNT2, KIAA0307: Aryl hydrocarbon receptor nuclear translocator 2 |
0.425 |
Evidence |
|
| ASCL1 |
ASCL1, ASH1: Achaete-scute homolog 1 |
BHLHB3 |
BHLHB3, DEC2, SHARP1: Class B basic helix-loop-helix protein 3 |
0.425 |
Evidence |
|
| SERPINB9 |
SERPINB9, PI9: Serpin B9 |
GZMB |
Endogenous granzyme B |
0.425 |
Evidence |
O
|
| ZNF165 |
ZNF165, ZPF165, ZSCAN7: Zinc finger protein 165 |
SSX1 |
SSX1: Protein SSX1 |
0.425 |
Evidence |
|
| GZMK |
GZMK, TRYP2: Granzyme K precursor |
SERPINB9 |
SERPINB9, PI9: Serpin B9 |
0.425 |
Evidence |
|
| CXCR3 |
CXCR3, GPR9: C-X-C chemokine receptor type 3 |
GNA13 |
GNA13: Guanine nucleotide-binding protein alpha-13 subunit |
0.425 |
Evidence |
|
| GPR109B |
GPR109B: Nicotinic acid receptor 2 |
GNAI2 |
Galphai2 protein |
0.425 |
Evidence |
|
| SERPINB4 |
SERPINB4, SCCA2: Serpin B4 |
KLK11 |
KLK11, PRSS20, UNQ649/PRO1279, TLSP: Kallikrein-11 precursor |
0.425 |
Evidence |
|
| KCNC1 |
KCNC1: Potassium voltage-gated channel subfamily C member 1 |
RYR2 |
RYR2: Ryanodine receptor 2 |
0.425 |
Evidence |
|
| RANGAP1 |
RANGAP1, SD: Ran GTPase-activating protein 1 |
BIRC2 |
BIRC2, API1, IAP2, MIHB, RNF48: Baculoviral IAP repeat-containing protein 2 |
0.425 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
MATK |
DKFZp434N1212, MATK, hCG_23522: Putative uncharacterized protein DKFZp434N1212 |
0.425 |
Evidence |
|
| GNAL |
GNAL: Guanine nucleotide-binding protein G(olf) subunit alpha |
EDG2 |
EDG2, LPA1: Lysophosphatidic acid receptor Edg-2 |
0.425 |
Evidence |
|
| SERPINF1 |
SERPINF1, PEDF: Pigment epithelium-derived factor precursor |
HABP2 |
HABP2, HGFAL, PHBP: Hyaluronan-binding protein 2 precursor |
0.425 |
Evidence |
|
| SCN4A |
SCN4A: Sodium channel protein type 4 subunit alpha |
RYR1 |
|
0.425 |
Evidence |
|
| CIITA |
CIITA, MHC2TA: MHC class II transactivator |
CARD8 |
CARD8, KIAA0955, NDPP1: Caspase recruitment domain-containing protein 8 |
0.425 |
Evidence |
|
| CIITA |
CIITA, MHC2TA: MHC class II transactivator |
QRICH1 |
IPI00328200 |
0.425 |
Evidence |
|
| CIITA |
CIITA, MHC2TA: MHC class II transactivator |
IRAK4 |
IRAK4: Interleukin-1 receptor-associated kinase 4 |
0.425 |
Evidence |
|
| CIITA |
CIITA, MHC2TA: MHC class II transactivator |
BIRC2 |
BIRC2, API1, IAP2, MIHB, RNF48: Baculoviral IAP repeat-containing protein 2 |
0.425 |
Evidence |
|
| CIITA |
CIITA, MHC2TA: MHC class II transactivator |
CASP4 |
CASP4, ICH2: Caspase-4 precursor |
0.425 |
Evidence |
|
| GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
SSTR5 |
SSTR5: Somatostatin receptor type 5 |
0.425 |
Evidence |
|
| CHRNA5 |
NACHRA5, CHRNA5: Neuronal acetylcholine receptor subunit alpha-5 precursor |
GABRG3 |
GABRG3: Gamma-aminobutyric acid receptor subunit gamma-3 precursor |
0.425 |
Evidence |
|
| HLA-F |
HLA-F, HLA-5.4, HLAF: HLA class I histocompatibility antigen, alpha chain F prec |
MICA |
MICA: MHC class I chain-related protein A |
0.425 |
Evidence |
|
| PDIA3 |
PDIA3, ERP57, ERP60, GRP58: Protein disulfide-isomerase A3 precursor |
ERO1L |
ERO1L, UNQ434/PRO865: ERO1-like protein alpha precursor |
0.425 |
Evidence |
|